Senior MSL – Italy Oncology Launch Leader
Salva questo lavoro e mantieni la tua ricerca organizzata
Crea un account gratuito per salvare lavori, creare avvisi e tornare a questa inserzione dalla tua dashboard.
Continuando accetti i nostri Termini & Informativa sulla privacy.
subrosa Health & Capital group is seeking a Senior Medical Science Liaison Manager (F/M/X) for Italy to support the launch of an innovative oncology therapy and to strengthen Medical Affairs with KOLs, HCPs and study sites across Italy.
You will lead peer‑to‑peer scientific exchanges, communicate clinical data, collaborate with cross‑functional teams and contribute to launch readiness and strategic medical planning in a fast‑growing biotechnolgy environment.
-
Senior Medical Science Liaison
4 ore fa
Sassari, Sardegna, Italia subrosa Health & Capital group Tempo pienoAn exciting oncology launch opportunity! Senior Medical Science Liaison Manager (F/M/X) Italy Our client is a pioneering oncology company developing innovative targeted therapies for patients with RAS-driven cancers, which account for approximately 30% of all cancer diagnoses worldwide. With a deep pipeline of RAS(ON) inhibitors, our client is redefining...
-
Sassari, Sardegna, Italia subrosa Health & Capital group Tempo pienosubrosa Health & Capital group is seeking a Senior Medical Science Liaison Manager (F/M/X) for Italy to support the launch of an innovative oncology therapy and to strengthen Medical Affairs with KOLs, HCPs and study sites across Italy.You will lead peer‑to‑peer scientific exchanges, communicate clinical data, collaborate with cross‑functional teams...
-
Senior Medical Science Liaison
1 giorno fa
Sassari, Sardegna, Italia subrosa Health & Capital group Tempo pienoAn exciting oncology launch opportunity! Senior Medical Science Liaison Manager (F/M/X) Italy Our client is a pioneering oncology company developing innovative targeted therapies for patients with RAS-driven cancers, which account for approximately 30% of all cancer diagnoses worldwide. With a deep pipeline of RAS(ON) inhibitors, our client is redefining...